Semaglutide GLP-1 works by regulating appetite and blood sugar, making it highly effective for weight loss
The current study used a systematic review and nonlinear meta-regression modeling approach to extrapolate weight loss trajectories beyond the last-reported follow-up time point after drug cessation
Availability has collapsed, as compounding was widely allowed during the FDA shortage
Accessed September 1, 2025.
In human medicine, these agents have demonstrated clinically meaningful weight loss with an acceptable safety profile when used within appropriate monitoring frameworks. Akston (the product developer) and Cornell University College of Veterinary Medicine in Ithaca, New York, have initiated a clinical study to evaluate AKS-562c, an Fc-fusion GLP-1 candidate, in client-owned cats
Prescription weight loss medications: In addition to semaglutide, there are other prescription weight loss medications like orlistat or phentermine